Once-daily oral pill could replace preoperative chemotherapy in patient population if validated in larger trials...
The post Talazoparib shows promise for early-stage BRCA+ breast cancer patients appeared first on European Pharmaceutical Review.
Original Article: Talazoparib shows promise for early-stage BRCA+ breast cancer patients